Controlled drug delivery systems based on in situ forming implants offer a versatile platform for achieving sustained and localised therapeutic release from a single administration. These systems ...

Sustained-release intraocular implants represent a rapidly advancing class of ophthalmic drug-delivery platforms engineered to maintain therapeutic intraocular concentrations over months to years. By ...

This shift is particularly critical in oncology and neurology, where maintaining therapeutic concentration at tumor or neural sites without damaging healthy tissues is essential. FMI analysis ...

Subcutaneous implants are injectable drug delivery systems effective for treatments lasting weeks to years. These implants ensure the active pharmaceutical ingredient (API) is released precisely where ...

Research teams at University of Galway and Massachusetts Institute of Technology (MIT) have detailed a breakthrough in medical device technology that could lead to intelligent, long-lasting, tailored ...

Add Popular Science (opens in a new tab) More information Adding us as a Preferred Source in Google by using this link indicates that you would like to see more of our content in Google News results.

May 9 (Reuters) - (To receive the full newsletter in your inbox for free sign up here) Ultrasound waves can penetrate through thick tissues and print medical implants inside a body, experiments in ...

Please provide your email address to receive an email when new articles are posted on . The development of drug delivery platforms that offer sustained release of therapeutic agents in the retina ...

Researchers with the University of Cincinnati and Johns Hopkins Medicine developed a potential treatment for brain cancer ...